European perspective on biosimilars

Bioanalysis. 2013 Mar;5(5):521-4. doi: 10.4155/bio.13.2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biosimilar Pharmaceuticals / analysis*
  • Biosimilar Pharmaceuticals / pharmacokinetics
  • Biosimilar Pharmaceuticals / standards
  • Europe
  • Government Regulation
  • Guidelines as Topic
  • Humans
  • Immunogenetic Phenomena
  • Reference Standards
  • Therapeutic Equivalency

Substances

  • Biosimilar Pharmaceuticals